Overview
Co-operative Insurance provides life and general insurance through specialised entities, with nationwide cooperative, branch and service-centre distribution. The latest filed quarter shows a substantial recovery in operating and net profit despite broadly flat revenue, but the valuation remains split: the shares are inexpensive against book value while earnings and income distributions offer less support.
Price performance
At LKR 3.30 on 9 November 2026, the share had gained 13.3% over one month against 6.0% for the ASPI, but remained down 37.0% over one year versus a 5.7% ASPI fall. The recent rebound therefore follows a much larger period of underperformance, rather than erasing it.
The price sits 23.1% of the way up its 52-week range and trading volume is 43.1% above its 60-day norm. The three-year record is four falls of 15% or more, the deepest 51%, which has not yet recovered. Median daily turnover was LKR 1.1 million: a LKR 1 million order is about 91% of what trades on a typical day, a large part of a day's trading.
Valuation
The shares trade at 19.4 times P/E, meaning LKR 19.4 is paid for every LKR 1 of trailing profit, above the insurance-sector median of 11.9 times. This leaves the earnings valuation dependent on the recent recovery being sustained rather than on a discount to peers.
The 0.83 times P/B means the market price is 83 cents for each LKR 1 of net assets, below the sector median of 1.52 times and the lowest among 11 insurance peers. It is also cheaper than 70% of days since December 2021. The latest audited-year ROE was 4.4%, so the low P/B coincides with a modest return being generated on that equity.
No trailing dividend yield is recorded. The latest dividend on file was LKR 0.05 per share for FY2024, versus LKR 0.135 for FY2021, while a dividend announced on 2 January 2026 still has no ex-date. The wider CSE valuation score is 34 of 100, in the Moderately overvalued band, driven by weaker earnings and dividend value despite the book-value discount.
News and sentiment
Direct coverage was normal over the past 90 days, with four material articles: one positive and three neutral. The main corporate development was the reported redemption of 1.1 million cumulative redeemable preference shares for LKR 16.6 million; these are preference shares and do not change the ordinary share count used for the valuation.
A final dividend disclosure was reported on 10 September, but the corporate-action record still describes the dividend as announced without an ex-date. Its timing remains uncertain, particularly as one older announcement is already past its usual ex-date window.
Financials
June-quarter revenue grew 0.7% year-on-year to LKR 1.6 billion, while operating profit rose 126.9% to LKR 144.6 million and net profit increased 136.4% to LKR 84.7 million. Profit therefore grew far faster than the premium and other revenue base supporting it.
Gross margin was 43.7%, but the prior June gross margin is not available for a like-for-like comparison. Operating margin widened from 4.0% to 9.1%, and net margin rose from 2.3% to 5.3%; the latest June operating and net margins each rank second among the comparable June quarters on record. Below operating profit, finance costs, tax and other items absorbed LKR 59.9 million, up from LKR 27.9 million a year earlier, so a sizeable part of operating profit did not reach shareholders.
Total equity increased from LKR 6.0 billion a year earlier to LKR 6.6 billion, while the ordinary share count remained 1.65 billion. The June filing is the latest available, so these results are historical as at 9 November 2026 rather than evidence about the unfiled September quarter.
Risks
The most material balance-sheet risk is the insurer's leverage through policy and other liabilities: total liabilities were 2.05 times equity at the latest audited year-end, up from 1.93 times a year earlier. This means LKR 2.05 of obligations stood behind each LKR 1 of equity, making underwriting performance and investment-portfolio movements important to the capital cushion.
The earnings recovery is also based on a modest revenue increase, while the June below-the-line drag more than doubled year-on-year. Separately, sector conditions as at 9 November included sharp bond-yield moves, which can affect insurers' fixed-income portfolio valuations and reinvestment yields, alongside rupee fluctuations relevant to foreign-currency reinsurance and claims costs.
Outlook
As at 9 November 2026, the next event is the September 2026 interim filing, which was due within the 2 to 14 November reporting window. It will show whether the June improvement in underwriting and operating profit carried into the following quarter, or whether the higher below-the-line charge remained a restraint.
The pending dividend has no ex-date, and the available data cannot establish its amount or timing. The filing and any dated dividend terms would therefore replace the June-quarter and income-distribution assumptions currently embedded in the analysis.